Not applicableUnknownNCT03668288What this trial is testingTolerance and Patients' Satisfaction With IGHyWho this might be right forSecondary or Primary Immunodeficiency CHU de Reims 20
Early research (Phase 1)Ended earlyNCT01249443What this trial is testingPaclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV InfectionWho this might be right forHIV InfectionRecurrent Anal CancerRecurrent Breast Cancer+31 more AIDS Malignancy Consortium 17
Not applicableUnknownNCT04382508What this trial is testingCoronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.Who this might be right forImmune SuppressionImmune DeficiencyInfection+2 more University Hospital Southampton NHS Foundation Trust 1,500
Large-scale testing (Phase 3)Study completedNCT04870333What this trial is testingPROphylaxis for paTiEnts at Risk of COVID-19 infecTion -VWho this might be right forCovid19 Cambridge University Hospitals NHS Foundation Trust 2,240
Not applicableStudy completedNCT00112593What this trial is testingFludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+176 more Fred Hutchinson Cancer Center 5
Not applicableStudy completedNCT02303093What this trial is testingNon-Interventional Study on the Tolerability and Efficacy of IVIGWho this might be right forPrimary and Secondary Immunodeficiency and Other Conditions Requiring Regular Administration of Octagam 5% or 10% IVIG Octapharma 344
Early research (Phase 1)Study completedNCT03329950What this trial is testingCDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesWho this might be right forMelanomaNon-small Cell Lung CancerBreast Cancer+23 more Celldex Therapeutics 132
Not applicableActive Not RecruitingNCT04354129What this trial is testingObservational Study of Subcutaneous Immunoglobulin (Cutaquig) in Patients With Primary and Secondary Immunodeficiency.Who this might be right forPrimary Immune Deficiency DisorderSecondary Immune Deficiency University of Alberta 36
Testing effectiveness (Phase 2)Study completedNCT00110045What this trial is testingCaspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell TransplantWho this might be right forCancer European Organisation for Research and Treatment of Cancer - EORTC 171